Hong Kong—BFB Health Limited’s monthly return for the period ended 31 March 2026 indicates no changes in either its authorised or issued share capital.
• Authorised capital remained at 100 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 1.00 billion.
• Issued share count stayed flat at 1.25 billion shares, and the company held no treasury shares.
• The public-float level met the Main Board’s 25% minimum requirement as of month-end.
Share-based incentives also showed no dilution impact during the month. The 2012 and 2021 share option schemes carried 22.26 million and 58.40 million outstanding options respectively, but no options were exercised in March, generating zero proceeds. The 2021 plan still allows a further 3.21 million shares to be granted.
The filing recorded no warrants, convertibles, share repurchases, or other equity movements.
Overall, BFB Health’s capital structure was unchanged through March 2026, and regulatory compliance—both on share issuance procedures and public float—was confirmed by the company secretary in the submission dated 9 April 2026.
Comments